Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Factor inhibiting hypoxia-inducible factor (FIH) is a 2-oxoglutarate and Fe(II)-dependent dioxygenase enzyme that catalyzes the hydroxylation of a conserved asparagine residue within the C-terminal transactivation domain of HIF-α proteins, restricting their ability to interact with transcriptional coactivators and thereby repressing HIF-mediated transcriptional activity under normal oxygen conditions (normoxia). FIH acts as a cellular oxygen sensor and regulates transcriptional responses to hypoxia. Apart from HIF-α, FIH also modifies proteins containing ankyrin repeat domains, though the biological significance of these modifications remains partly unresolved. Due to its central role in oxygen-dependent gene regulation, FIH is being explored as a drug target in diseases such as cancer and ischemia, where hypoxia and metabolic regulation are critical.
Inhibition of FIH enzymatic activity (asparaginyl hydroxylase), resulting in reduced hydroxylation of HIF-α, enhanced HIF-α transcriptional activity, and upregulated cellular hypoxic response Modulation of oxygen sensing and adaptation via alteration of HIF target gene expression
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Factor inhibiting hypoxia-inducible factor (FIH).